XPhyto Therapeutic Corporation (XPHYF) Corporate Media Kit

Buy and Build Strategy 04. 2020 09. 2019 12. 2018 Experts in thin film drug delivery systems for transdermal and oral dissolvable dosage forms Near-term focus on development and clinical validation of cannabis extract “kits” for pharmaceutical compounding in Germany XPhyto’s buy and build strategy is creating a portfolio of late-stage therapeutic and diagnostic products Rapid, low-cost pathogen screening tests for pandemic and oral health applications XPhyto Therapeutics Corporation A next generation bioscience company | BUNKER Pflanzenextrakte GmbH Acquisition Vektor Pharma TF GmbH Acquisition 3a-diagnostics GmbH Exclusive Agreement XPhyto Founded 5 Two psychedelic medicine collaborations underway with leading institutions in Germany and Canada University of Alberta & Leading German University Collaborations 02. 2021 2017